Departments of Pathology.
Oncology.
Am J Surg Pathol. 2022 Aug 1;46(8):1153-1159. doi: 10.1097/PAS.0000000000001894. Epub 2022 Apr 5.
Identical TFE3-related gene fusions may be found in renal cell carcinoma and mesenchymal neoplasms such as alveolar soft part sarcoma and TFE3-rearranged perivascular epithelioid cell tumor (PEComa). Among mesenchymal neoplasms, the ASPSCR1-TFE3 gene fusion has previously been described only in alveolar soft part sarcoma. We report 3 unusual mesenchymal neoplasms harboring the ASPSCR1-TFE3 gene fusion, the morphologic phenotype of which more closely matches PEComa rather than alveolar soft part sarcoma. All 3 neoplasms occurred in females ranging in age from 18 to 34 years and were located in the viscera (kidney, bladder, and uterus). All 3 contained nests of epithelioid cells bounded by fibrovascular septa. However, all were associated with hyalinized stroma, tight nested architecture, mixed spindle cell and epithelioid pattern, clear cytoplasm, and lacked significant discohesion. Overall, morphologic features closely resembled PEComa, being distinct from the typical alveolar soft part sarcoma phenotype. While none of the neoplasms labeled for HMB45, cytokeratin, or PAX8 all showed positivity for TFE3 and cathepsin K, and all except 1 were positive for smooth muscle actin. One patient developed a liver metastasis 7 years after nephrectomy. These cases bridge the gap between 2 TFE3-rearranged neoplasms, specifically alveolar soft part sarcoma and Xp11 translocation PEComa, highlighting the relatedness and overlap among Xp11 translocation neoplasms. While most TFE3-rearranged neoplasms can be confidently placed into a specific diagnostic category such as alveolar soft part sarcoma, PEComa, or Xp11 translocation renal cell carcinoma, occasional cases have overlapping features, highlighting the potential role that the cell of origin and the specific gene fusion play in the phenotype of these neoplasms.
在肾细胞癌和间叶性肿瘤(如腺泡状软组织肉瘤和 TFE3 重排的血管周上皮样细胞瘤(PEComa))中可能发现相同的 TFE3 相关基因融合。在间叶性肿瘤中,ASPSCR1-TFE3 基因融合以前仅在腺泡状软组织肉瘤中被描述。我们报告了 3 例不寻常的含有 ASPSCR1-TFE3 基因融合的间叶性肿瘤,其形态表型更接近 PEComa,而不是腺泡状软组织肉瘤。这 3 种肿瘤均发生于女性,年龄 18 至 34 岁,位于内脏(肾、膀胱和子宫)。所有 3 种肿瘤均包含上皮样细胞巢,由纤维血管间隔包围。然而,所有肿瘤均伴有玻璃样基质、紧密的巢状结构、混合梭形细胞和上皮样模式、透明细胞质,且缺乏明显的分离。总的来说,形态学特征与 PEComa 非常相似,与典型的腺泡状软组织肉瘤表型明显不同。虽然没有一种肿瘤标记 HMB45、细胞角蛋白或 PAX8,但所有肿瘤均显示 TFE3 和组织蛋白酶 K 阳性,除 1 例外,所有肿瘤均显示平滑肌肌动蛋白阳性。1 例患者在肾切除术后 7 年发生肝转移。这些病例填补了 2 种 TFE3 重排肿瘤(即腺泡状软组织肉瘤和 Xp11 易位性 PEComa)之间的空白,突出了 Xp11 易位性肿瘤之间的相关性和重叠性。虽然大多数 TFE3 重排肿瘤可以明确归入特定的诊断类别,如腺泡状软组织肉瘤、PEComa 或 Xp11 易位性肾细胞癌,但偶尔也会出现重叠特征,这突出了起源细胞和特定基因融合在这些肿瘤表型中的潜在作用。